The docking binding free energies (ΔG) of the synthesized compounds with DNA-topoisomerase II complex. by Ahmed A. Gaber (13302308)

The rationale of molecular design of new DNA-intercalators. by Ahmed A. Gaber (13302308)

Resveratrol decreases PKM2 expression. by Mohd Askandar Iqbal (324124)

“…Western blot showing decreased PKM2 protein in all the cell lines studied on treatment with 50 µM resveratrol (D). …”

Concentration dependent decrease of mtDNA. by Richard de Boer (526887)

βPix-d regulates neurite outgrowth and the phosphorylation of Stathmin1 at Ser16. by Younghee Kwon (1823413)

“…(E) The longest neurite shown in Fig 5A are straightened using ImageJ software. (F) In the longest neurite, the phosphorylation levels of Stathmin1 at Ser16, which are normalized to β3-tubulin, decreases by 20% in the NIKO+GFP neurons compared with the WT+GFP neurons. …”

AKT inhibition decreases neuroblast populations. by Maria R. Aburto (186884)

“…The data are shown as the mean ± SEM and the statistical significance between the different conditions was estimated by Student's t-test: *P<0.05, ***P<0.001, versus control (0S). …”

Ellagic acid decreases lysosomal integrity. by Ahmad Salimi (10204515)

Ellagic acid decreases ROS formation. by Ahmad Salimi (10204515)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Ellagic acid decreases mitochondrial damages. by Ahmad Salimi (10204515)

Protocatechuic aldehyde decreases ROS production. by Byung Soo Kong (663779)

Simvastatin decreases eNOS expression. by Mohammed Sabri (355717)

The interaction between TLCYnV C4 and DRM2 decreases the methylation level of endogenous DRM2-targets genes in tobacco. by Yuzhen Mei (4730877)

rs6441201 risk allele at 3q25 correlates with increased <i>MLF1</i> expression and <i>MLF1</i> silencing results in decreased cell growth in neuroblastoma cells. by Lee D. McDaniel (4033088)

A rough draft of a working systems-map. by Thi Hoang Vu (13268033)

Decreased reductase activity and increased round body formation in the <i>gpsA</i> mutant. by Dan Drecktrah (36180)

At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…</b> * = <i>P</i><0.05, ** = <i>P</i><.01, *** = <i>P</i><.001; different from drug free. Error bars depict mean ± SEM.</p>…”

Metal-reactive lymphocytes from individuals’ exhibit significant decreased metal-reactivity when IL-1 and IL-17A bioactivity is inhibited <i>in vitro</i>. by Lauryn Samelko (424639)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Drp1^SD overexpression partially alleviates the differentiation defect seen in <i>notch</i> RNAi expressing type II NB lineages. by Dnyanesh Dubal (12085942)